Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 1
2017 1
2018 2
2019 3
2020 2
2021 2
2022 2
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Results by year

Filters applied: . Clear all
Page 1
TET2 mutational status affects myelodysplastic syndrome evolution to chronic myelomonocytic leukemia.
Quang VT, Podvin B, Desterke C, Tarfi S, Barathon Q, Badaoui B, Freynet N, Parinet V, Leclerc M, Maury S, Solary E, Selimoglu-Buet D, Duployez N, Wagner-Ballon O, Sloma I. Quang VT, et al. Among authors: freynet n. Haematologica. 2023 Nov 1;108(11):3135-3141. doi: 10.3324/haematol.2022.282528. Haematologica. 2023. PMID: 37102610 Free PMC article. No abstract available.
Reference Values for WBC Differential by Hematoflow Analysis.
Magierowicz M, Lechevalier N, Freynet N, Pastoret C, Badaoui B, Ly-Sunnaram B, Fest T, Lacombe F, Wagner-Ballon O, Roussel M. Magierowicz M, et al. Among authors: freynet n. Am J Clin Pathol. 2019 Feb 4;151(3):324-327. doi: 10.1093/ajcp/aqy147. Am J Clin Pathol. 2019. PMID: 30383211
Machine learning identifies the independent role of dysplasia in the prediction of response to chemotherapy in AML.
Duchmann M, Wagner-Ballon O, Boyer T, Cheok M, Fournier E, Guerin E, Fenwarth L, Badaoui B, Freynet N, Benayoun E, Lusina D, Garcia I, Gardin C, Fenaux P, Pautas C, Quesnel B, Turlure P, Terré C, Thomas X, Lambert J, Renneville A, Preudhomme C, Dombret H, Itzykson R, Cluzeau T. Duchmann M, et al. Among authors: freynet n. Leukemia. 2022 Mar;36(3):656-663. doi: 10.1038/s41375-021-01435-7. Epub 2021 Oct 6. Leukemia. 2022. PMID: 34615986 Clinical Trial.
How should we diagnose and treat blastic plasmacytoid dendritic cell neoplasm patients?
Garnache-Ottou F, Vidal C, Biichlé S, Renosi F, Poret E, Pagadoy M, Desmarets M, Roggy A, Seilles E, Soret L, Schillinger F, Puyraimond S, Petrella T, Preudhomme C, Roumier C, MacIntyre EA, Harrivel V, Desbrosses Y, Gruson B, Geneviève F, Thepot S, Drebit Y, Leguay T, Gros FX, Lechevalier N, Saussoy P, Salaun V, Cornet E, Benseddik Z, Veyrat-Masson R, Wagner-Ballon O, Salanoubat C, Maynadié M, Guy J, Caillot D, Jacob MC, Cahn JY, Gressin R, Rose J, Quesnel B, Guerin E, Trimoreau F, Feuillard J, Gourin MP, Plesa A, Baseggio L, Arnoux I, Vey N, Blaise D, Lacroix R, Arnoulet C, Benet B, Dorvaux V, Bret C, Drenou B, Debliquis A, Latger-Cannard V, Bonmati C, Bene MC, Peterlin P, Ticchioni M, Rohrlich PS, Arnaud A, Wickenhauser S, Bardet V, Brechignac S, Papoular B, Raggueneau V, Vargaftig J, Letestu R, Lusina D, Braun T, Foissaud V, Tamburini J, Bennani H, Freynet N, Cordonnier C, Le Garff-Tavernier M, Jacques N, Maloum K, Roos-Weil D, Bouscary D, Asnafi V, Lhermitte L, Suarez F, Lengline E, Féger F, Battipaglia G, Mohty M, Bouyer S, Ghoual O, Dindinaud E, Basle C, Puyade M, Lafon C, Fest T, Roussel M, Cahu X, Bera E, Daliphard S, Jardin F, Campos L, Solly F, Guyotat D, Galoisy … See abstract for full author list ➔ Garnache-Ottou F, et al. Among authors: freynet n. Blood Adv. 2019 Dec 23;3(24):4238-4251. doi: 10.1182/bloodadvances.2019000647. Blood Adv. 2019. PMID: 31869411 Free PMC article.
Prognostic value of monocyte subset distribution in chronic myelomonocytic leukemia: results of a multicenter study.
Jestin M, Tarfi S, Duchmann M, Badaoui B, Freynet N, Tran Quang V, Sloma I, Droin N, Morabito M, Leclerc M, Maury S, Fenaux P, Solary E, Selimoglu-Buet D, Wagner-Ballon O; Groupe Francophone des Myélodysplasies (GFM). Jestin M, et al. Among authors: freynet n. Leukemia. 2021 Mar;35(3):893-896. doi: 10.1038/s41375-020-0955-1. Epub 2020 Jul 20. Leukemia. 2021. PMID: 32684630 No abstract available.
High sensitivity of the Hematoflow™ solution for chronic myelomonocytic leukemia screening.
Vazquez R, Roussel M, Badaoui B, Freynet N, Tarfi S, Solary E, Selimoglu-Buet D, Wagner-Ballon O; Groupe Francophone des Myélodysplasies (GFM). Vazquez R, et al. Among authors: freynet n. Cytometry B Clin Cytom. 2018 Sep;94(5):658-661. doi: 10.1002/cyto.b.21600. Epub 2017 Nov 16. Cytometry B Clin Cytom. 2018. PMID: 29108126 Free article.
Disappearance of slan-positive non-classical monocytes for diagnosis of chronic myelomonocytic leukemia with associated inflammatory state.
Tarfi S, Badaoui B, Freynet N, Morabito M, Lafosse J, Toma A, Etienne G, Micol JB, Sloma I, Fenaux P, Solary E, Selimoglu-Buet D, Wagner-Ballon O; Groupe Francophone des Myelodysplasies (GFM). Tarfi S, et al. Among authors: freynet n. Haematologica. 2019 Aug 14:haematol.2019.219782. doi: 10.3324/haematol.2019.219782. Online ahead of print. Haematologica. 2019. PMID: 31413091 Free article.
11 results